Survival outcome of patients with relapsed or refractory classical Hodgkin lymphoma who achieved remission during immune checkpoint inhibitors treatment.
JOURNAL OF CLINICAL ONCOLOGY(2022)
关键词
refractory classical hodgkin lymphoma,immune checkpoint inhibitors treatment,remission
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要